Literature DB >> 21175903

Smoking and the outcome of infection.

R Huttunen1, T Heikkinen, J Syrjänen.   

Abstract

Smoking has substantial local and systemic adverse effects on the immune system, respiratory tract and skin and soft tissues. Smokers are at increased risk of invasive pneumococcal disease, pneumonia, periodontitis, surgical infections, tuberculosis, influenza and meningococcal disease. The results of several studies indicate that smokers with periodontitis or tuberculosis suffer more severe disease. Data on the impact of smoking on sepsis and pneumonia are controversial and limited, and systematic data regarding the outcome of the majority of infections in smokers are scarce. Abundant data indicate that children exposed to environmental tobacco smoke (ETS) suffer from more severe infections. However, information regarding the effects of ETS on the outcome of infections in adults is limited. Various aspects of the relation between smoking and the outcome of bacterial infection (e.g. potential dose-dependent effects and the interactions between smoking and other environmental factors that may affect the course of infectious diseases) remain to be established.
© 2010 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21175903     DOI: 10.1111/j.1365-2796.2010.02332.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  47 in total

1.  Cross-talk between clinical and host-response parameters of periodontitis in smokers.

Authors:  R Nagarajan; C S Miller; D Dawson; M Al-Sabbagh; J L Ebersole
Journal:  J Periodontal Res       Date:  2016-07-19       Impact factor: 4.419

2.  Smoking is associated with aggravated kidney injury in Puumala hantavirus-induced haemorrhagic fever with renal syndrome.

Authors:  Laura Tervo; Satu Mäkelä; Jaana Syrjänen; Reetta Huttunen; Arja Rimpelä; Heini Huhtala; Olli Vapalahti; Antti Vaheri; Jukka Mustonen
Journal:  Nephrol Dial Transplant       Date:  2015-07-05       Impact factor: 5.992

3.  The immune system as a victim and aggressor in chronic obstructive pulmonary disease.

Authors:  Joshua J C McGrath; Martin R Stampfli
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

4.  Mortality, asthma, smoking and acute chest syndrome in young adults with sickle cell disease.

Authors:  Jennifer M Knight-Madden; Antoinette Barton-Gooden; Steve R Weaver; Marvin Reid; Anne Greenough
Journal:  Lung       Date:  2012-11-13       Impact factor: 2.584

5.  A Review of the Literature Concerning HIV and Cigarette Smoking: Morbidity and Mortality, Associations with Individual- and Social-Level Characteristics, and Smoking Cessation Efforts.

Authors:  Lauren R Pacek; Rosa M Crum
Journal:  Addict Res Theory       Date:  2014-05-19

Review 6.  Effects of air pollutants on innate immunity: the role of Toll-like receptors and nucleotide-binding oligomerization domain-like receptors.

Authors:  Rebecca N Bauer; David Diaz-Sanchez; Ilona Jaspers
Journal:  J Allergy Clin Immunol       Date:  2012-01       Impact factor: 10.793

7.  The effect of obesity on clinical outcomes in presumed sepsis: a retrospective cohort study.

Authors:  Timothy Glen Gaulton; Mark Gordon Weiner; Knashawn Hodge Morales; David Foster Gaieski; Jimish Mehta; Ebbing Lautenbach
Journal:  Intern Emerg Med       Date:  2013-09-27       Impact factor: 3.397

8.  Smoking-related cotinine levels and host responses in chronic periodontitis.

Authors:  J L Ebersole; M J Steffen; M V Thomas; M Al-Sabbagh
Journal:  J Periodontal Res       Date:  2013-11-27       Impact factor: 4.419

9.  Smoking association with influenza infection in renal transplant recipients.

Authors:  J A Sparks; D C Brennan; S J Lawrence
Journal:  Transpl Infect Dis       Date:  2013-11-12       Impact factor: 2.228

10.  Life-threatening complications of deep neck space infections.

Authors:  Daniel Dalla Torre; Silvia Brunold; Irene Kisielewsky; Frank R Kloss; Doris Burtscher
Journal:  Wien Klin Wochenschr       Date:  2013-10-22       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.